Atopic Dermatitis (Eczema) Treatment - Global and China Top Players Market Share and Ranking 2025
Atopic Dermatitis (Eczema) Treatment - Global and China Top Players Market Share and Ranking 2025
The Atopic Dermatitis (Eczema) Treatment Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
• The global Atopic Dermatitis (Eczema) Treatment market was valued at US$ XX Million in 2024
• It is estimated to expand at a CAGR of % from 2024 to 2031
• The global Atopic Dermatitis (Eczema) Treatment market is expected to reach the value of US$ XX Million by the end of 2031
Atopic Dermatitis (Eczema) Treatment Market Overview
Atopic dermatitis is a chronic disease that causes inflammation of the skin and results in red, itchy, swollen, and cracked skin.
Market Snapshot
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report studies and analyses global Atopic Dermatitis (Eczema) Treatment status and future trends, helping the client to determine the Atopic Dermatitis (Eczema) Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Atopic Dermatitis (Eczema) Treatment. It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.
Atopic Dermatitis (Eczema) Treatment Market Key Takeaways
(1) Global Atopic Dermatitis (Eczema) Treatment market size, history data 2020-2024 , and forecast data 2024 -2031, (US$ million) & (K Units)
(2) Global Atopic Dermatitis (Eczema) Treatment sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(3) China Atopic Dermatitis (Eczema) Treatment sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(4) Global Atopic Dermatitis (Eczema) Treatment key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Atopic Dermatitis (Eczema) Treatment key producing regions, capacity, production, and year-over-year growth
(6) Atopic Dermatitis (Eczema) Treatment industry chains, upstream, midstream, and downstream
Atopic Dermatitis (Eczema) Treatment Market: Key Players
The competitive landscape of the Atopic Dermatitis (Eczema) Treatment Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Atopic Dermatitis (Eczema) Treatment Market. Some of the major players operating in the Atopic Dermatitis (Eczema) Treatment Market are:
- Sanofi
- Allergan
- Novartis
- Bristol Myers Squibb
- Bayer
- Meda Pharmaceuticals
- Anacor Pharmaceutical
- Pfizer
- Astellas Pharma
- Regeneron Pharmaceuticals
Market IntelliX's study on the Atopic Dermatitis (Eczema) Treatment market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Atopic Dermatitis (Eczema) Treatment Market by Type [Analysis by Value from 2020 to 2031]:
- Topical
- Oral
- Injectable
Atopic Dermatitis (Eczema) Treatment Market by Application [Analysis by Value from 2020 to 2031]:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Atopic Dermatitis (Eczema) Treatment Market by Region [Analysis by Value from 2020 to 2031]:
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
- South America (Brazil, Argentina and Colombia etc.)
- Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
Atopic Dermatitis (Eczema) Treatment Market Report Includes:
Chapter 1: To describe Atopic Dermatitis (Eczema) Treatment product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Atopic Dermatitis (Eczema) Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024
Chapter 3: China Atopic Dermatitis (Eczema) Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024
Chapter 4: Global key producing regions of Atopic Dermatitis (Eczema) Treatment , percent & CAGR, 2020 - 2031
Chapter 5: Atopic Dermatitis (Eczema) Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Atopic Dermatitis (Eczema) Treatment Definition
1.2 Global Atopic Dermatitis (Eczema) Treatment Market Size and Forecast
1.2.1 By Consumption Value, Global Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
1.2.3 Global Atopic Dermatitis (Eczema) Treatment Average Selling Price (ASP), 2020-2031
1.3 China Atopic Dermatitis (Eczema) Treatment Market Size and Forecast
1.3.1 By Consumption Value, China Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
1.3.2 By Sales Quantity, China Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
1.3.3 China Atopic Dermatitis (Eczema) Treatment Average Selling Price (ASP), 2020-2031
1.4 Share of China Atopic Dermatitis (Eczema) Treatment Market with Respect to the Global Market
1.4.1 By Consumption Value, China Atopic Dermatitis (Eczema) Treatment Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Atopic Dermatitis (Eczema) Treatment Market Share in Global, 2020-2031
1.4.3 Atopic Dermatitis (Eczema) Treatment Market Size: China VS Global, 2020-2031
1.5 Atopic Dermatitis (Eczema) Treatment Market Dynamics
1.5.1 Atopic Dermatitis (Eczema) Treatment Market Drivers
1.5.2 Atopic Dermatitis (Eczema) Treatment Market Restraints
1.5.3 Atopic Dermatitis (Eczema) Treatment Industry Trends
1.5.4 Atopic Dermatitis (Eczema) Treatment Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Atopic Dermatitis (Eczema) Treatment, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Atopic Dermatitis (Eczema) Treatment, Global Market Share by Company, 2020-2025
2.3 Atopic Dermatitis (Eczema) Treatment Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Atopic Dermatitis (Eczema) Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Atopic Dermatitis (Eczema) Treatment Concentration Ratio
2.6 Global Atopic Dermatitis (Eczema) Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Atopic Dermatitis (Eczema) Treatment Manufacturers Product Type
2.8 Head Office and Atopic Dermatitis (Eczema) Treatment Production Site of Key Manufacturer
2.9 Atopic Dermatitis (Eczema) Treatment Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Atopic Dermatitis (Eczema) Treatment, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Atopic Dermatitis (Eczema) Treatment, China Market Share by Company, 2020-2025
3.3 China Atopic Dermatitis (Eczema) Treatment Atopic Dermatitis (Eczema) Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Atopic Dermatitis (Eczema) Treatment Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Atopic Dermatitis (Eczema) Treatment Capacity by Region
4.3 Global Atopic Dermatitis (Eczema) Treatment Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Atopic Dermatitis (Eczema) Treatment Production by Region, 2020-2031
4.5 Global Atopic Dermatitis (Eczema) Treatment Production Market Share & Forecast by Region, 2020-2031
5 Industry Chain Analysis
5.1 Atopic Dermatitis (Eczema) Treatment Industry Chain
5.2 Atopic Dermatitis (Eczema) Treatment Upstream Analysis
5.2.1 Atopic Dermatitis (Eczema) Treatment Core Raw Materials
5.2.2 Main Manufacturers of Atopic Dermatitis (Eczema) Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Atopic Dermatitis (Eczema) Treatment Production Mode
5.6 Atopic Dermatitis (Eczema) Treatment Procurement Model
5.7 Atopic Dermatitis (Eczema) Treatment Industry Sales Model and Sales Channels
5.7.1 Atopic Dermatitis (Eczema) Treatment Sales Model
5.7.2 Atopic Dermatitis (Eczema) Treatment Typical Distributors
6 Sights by Product Type
6.1 Atopic Dermatitis (Eczema) Treatment Classification
6.1.1 Topical
6.1.2 Oral
6.1.3 Injectable
6.2 by Type, Global Atopic Dermatitis (Eczema) Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Atopic Dermatitis (Eczema) Treatment Consumption Value, 2020-2031
6.4 by Type, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031
6.5 by Type, Global Atopic Dermatitis (Eczema) Treatment Average Selling Price (ASP), 2020-2031
7 Sights by Application
7.1 Atopic Dermatitis (Eczema) Treatment Segment by Application
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.2 by Application, Global Atopic Dermatitis (Eczema) Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Atopic Dermatitis (Eczema) Treatment Consumption Value, 2020-2031
7.4 by Application, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031
7.5 by Application, Global Atopic Dermatitis (Eczema) Treatment Price, 2020-2031
8 Sales Sights by Region
8.1 By Region, Global Atopic Dermatitis (Eczema) Treatment Consumption Value, 2020 VS 2024 VS 2031
8.2 By Region, Global Atopic Dermatitis (Eczema) Treatment Consumption Value, 2020-2031
8.3 By Region, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031
8.4 North America
8.4.1 North America Atopic Dermatitis (Eczema) Treatment Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Atopic Dermatitis (Eczema) Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Atopic Dermatitis (Eczema) Treatment Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Atopic Dermatitis (Eczema) Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Atopic Dermatitis (Eczema) Treatment Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Atopic Dermatitis (Eczema) Treatment Market Size Market Share
8.7 South America
8.7.1 South America Atopic Dermatitis (Eczema) Treatment Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Atopic Dermatitis (Eczema) Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Atopic Dermatitis (Eczema) Treatment Market Size & CAGR, 2020 VS 2024 VS 2031
9.2 By Country, Global Atopic Dermatitis (Eczema) Treatment Consumption Value, 2020-2031
9.3 By Country, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031
9.4 United States
9.4.1 United States Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
9.4.2 by Type, United States Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.4.3 by Application, United States Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
9.5.2 by Type, Europe Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.5.3 by Application, Europe Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.6 China
9.6.1 China Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
9.6.2 by Type, China Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.6.3 by Application, China Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
9.7.2 by Type, Japan Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.7.3 by Application, Japan Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
9.8.2 by Type, South Korea Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.8.3 by Application, South Korea Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
9.9.2 by Type, Southeast Asia Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.9.3 by Application, Southeast Asia Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.10 India
9.10.1 India Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
9.10.2 by Type, India Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.10.3 by Application, India Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Atopic Dermatitis (Eczema) Treatment Market Size, 2020-2031
9.11.2 by Type, Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
9.11.3 by Application, Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
10 Manufacturers Profile
10.1 Sanofi
10.1.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.1.2 Sanofi Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
10.1.3 Sanofi Atopic Dermatitis (Eczema) Treatment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Sanofi Company Profile and Main Business
10.1.5 Sanofi Recent Developments
10.2 Allergan
10.2.1 Allergan Company Information, Head Office, Market Area, and Industry Position
10.2.2 Allergan Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
10.2.3 Allergan Atopic Dermatitis (Eczema) Treatment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Allergan Company Profile and Main Business
10.2.5 Allergan Recent Developments
10.3 Novartis
10.3.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.3.2 Novartis Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
10.3.3 Novartis Atopic Dermatitis (Eczema) Treatment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Novartis Company Profile and Main Business
10.3.5 Novartis Recent Developments
10.4 Bristol Myers Squibb
10.4.1 Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
10.4.2 Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
10.4.3 Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Bristol Myers Squibb Company Profile and Main Business
10.4.5 Bristol Myers Squibb Recent Developments
10.5 Bayer
10.5.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.5.2 Bayer Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
10.5.3 Bayer Atopic Dermatitis (Eczema) Treatment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.5.4 Bayer Company Profile and Main Business
10.5.5 Bayer Recent Developments
10.6 Meda Pharmaceuticals
10.6.1 Meda Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.6.2 Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
10.6.3 Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Meda Pharmaceuticals Company Profile and Main Business
10.6.5 Meda Pharmaceuticals Recent Developments
10.7 Anacor Pharmaceutical
10.7.1 Anacor Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.7.2 Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
10.7.3 Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Anacor Pharmaceutical Company Profile and Main Business
10.7.5 Anacor Pharmaceutical Recent Developments
10.8 Pfizer
10.8.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.8.2 Pfizer Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
10.8.3 Pfizer Atopic Dermatitis (Eczema) Treatment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Pfizer Company Profile and Main Business
10.8.5 Pfizer Recent Developments
10.9 Astellas Pharma
10.9.1 Astellas Pharma Company Information, Head Office, Market Area, and Industry Position
10.9.2 Astellas Pharma Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
10.9.3 Astellas Pharma Atopic Dermatitis (Eczema) Treatment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Astellas Pharma Company Profile and Main Business
10.9.5 Astellas Pharma Recent Developments
10.10 Regeneron Pharmaceuticals
10.10.1 Regeneron Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.10.2 Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
10.10.3 Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.10.4 Regeneron Pharmaceuticals Company Profile and Main Business
10.10.5 Regeneron Pharmaceuticals Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Atopic Dermatitis (Eczema) Treatment Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Atopic Dermatitis (Eczema) Treatment Market Restraints
Table 3. Atopic Dermatitis (Eczema) Treatment Market Trends
Table 4. Atopic Dermatitis (Eczema) Treatment Industry Policy
Table 5. Global Atopic Dermatitis (Eczema) Treatment Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Atopic Dermatitis (Eczema) Treatment Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 7. Global Atopic Dermatitis (Eczema) Treatment Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024
Table 8. Global Atopic Dermatitis (Eczema) Treatment Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
Table 9. Global Atopic Dermatitis (Eczema) Treatment Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)
Table 10. Global Atopic Dermatitis (Eczema) Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Atopic Dermatitis (Eczema) Treatment Mergers & Acquisitions, Expansion Plans
Table 12. Global Atopic Dermatitis (Eczema) Treatment Manufacturers Product Type
Table 13. Head Office and Atopic Dermatitis (Eczema) Treatment Production Site of Key Manufacturer
Table 14. Atopic Dermatitis (Eczema) Treatment Capacity of Major Manufacturers and Future Plan
Table 15. China Atopic Dermatitis (Eczema) Treatment Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 16. China Atopic Dermatitis (Eczema) Treatment Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 17. China Atopic Dermatitis (Eczema) Treatment Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024
Table 18. China Atopic Dermatitis (Eczema) Treatment Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
Table 19. Global Atopic Dermatitis (Eczema) Treatment Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)
Table 20. Global Atopic Dermatitis (Eczema) Treatment Production by Region, 2020-2025, (K Units)
Table 21. Global Atopic Dermatitis (Eczema) Treatment Production Forecast by Region, 2026-2031, (K Units)
Table 22. Global Key Players of Atopic Dermatitis (Eczema) Treatment Upstream (Raw Materials)
Table 23. Global Atopic Dermatitis (Eczema) Treatment Typical Customers
Table 24. Atopic Dermatitis (Eczema) Treatment Typical Distributors
Table 25. by Type, Global Atopic Dermatitis (Eczema) Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 26. by Application, Global Atopic Dermatitis (Eczema) Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 27. By Region, Global Atopic Dermatitis (Eczema) Treatment Consumption Value, 2020 VS 2024 VS 2031, US$ Million
Table 28. By Region, Global Atopic Dermatitis (Eczema) Treatment Consumption Value, 2020-2031, US$ Million
Table 29. By Region, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Table 30. By Country, Global Atopic Dermatitis (Eczema) Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 31. By Country, Global Atopic Dermatitis (Eczema) Treatment Consumption Value, 2020-2031, US$ Million
Table 32. By Country, Global Atopic Dermatitis (Eczema) Treatment Consumption Value Market Share, 2020-2031
Table 33. By Country, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Table 34. By Country, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2020-2031
Table 35. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 36. Sanofi Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
Table 37. Sanofi Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 38. Sanofi Company Profile and Main Business
Table 39. Sanofi Recent Developments
Table 40. Allergan Company Information, Head Office, Market Area, and Industry Position
Table 41. Allergan Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
Table 42. Allergan Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 43. Allergan Company Profile and Main Business
Table 44. Allergan Recent Developments
Table 45. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 46. Novartis Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
Table 47. Novartis Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 48. Novartis Company Profile and Main Business
Table 49. Novartis Recent Developments
Table 50. Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
Table 51. Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
Table 52. Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 53. Bristol Myers Squibb Company Profile and Main Business
Table 54. Bristol Myers Squibb Recent Developments
Table 55. Bayer Company Information, Head Office, Market Area, and Industry Position
Table 56. Bayer Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
Table 57. Bayer Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 58. Bayer Company Profile and Main Business
Table 59. Bayer Recent Developments
Table 60. Meda Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 61. Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
Table 62. Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 63. Meda Pharmaceuticals Company Profile and Main Business
Table 64. Meda Pharmaceuticals Recent Developments
Table 65. Anacor Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 66. Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
Table 67. Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 68. Anacor Pharmaceutical Company Profile and Main Business
Table 69. Anacor Pharmaceutical Recent Developments
Table 70. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 71. Pfizer Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
Table 72. Pfizer Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 73. Pfizer Company Profile and Main Business
Table 74. Pfizer Recent Developments
Table 75. Astellas Pharma Company Information, Head Office, Market Area, and Industry Position
Table 76. Astellas Pharma Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
Table 77. Astellas Pharma Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 78. Astellas Pharma Company Profile and Main Business
Table 79. Astellas Pharma Recent Developments
Table 80. Regeneron Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 81. Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Models, Specifications, and Application
Table 82. Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 83. Regeneron Pharmaceuticals Company Profile and Main Business
Table 84. Regeneron Pharmaceuticals Recent Developments
List of Figures
Figure 1. Atopic Dermatitis (Eczema) Treatment Picture
Figure 2. Global Atopic Dermatitis (Eczema) Treatment Consumption Value, (US$ million) & (2020-2031)
Figure 3. Global Atopic Dermatitis (Eczema) Treatment Sales Quantity, (K Units) & (2020-2031)
Figure 4. Global Atopic Dermatitis (Eczema) Treatment Average Selling Price (ASP), (2020-2031) & (US$/Unit)
Figure 5. China Atopic Dermatitis (Eczema) Treatment Consumption Value, (US$ million) & (2020-2031)
Figure 6. China Atopic Dermatitis (Eczema) Treatment Sales Quantity (K Units) & (2020-2031)
Figure 7. China Atopic Dermatitis (Eczema) Treatment Average Selling Price (ASP), (US$/Unit) & (2020-2031)
Figure 8. By Consumption Value, China Atopic Dermatitis (Eczema) Treatment Market Share of Global, 2020-2031
Figure 9. By Sales Quantity, China Atopic Dermatitis (Eczema) Treatment Market Share of Global, 2020-2031
Figure 10. Global Atopic Dermatitis (Eczema) Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 11. China Atopic Dermatitis (Eczema) Treatment Key Participants, Market Share, 2024
Figure 12. Global Atopic Dermatitis (Eczema) Treatment Capacity, Production and Capacity Utilization, 2020-2031
Figure 13. Global Atopic Dermatitis (Eczema) Treatment Capacity Market Share by Region, 2024 VS 2031
Figure 14. Global Atopic Dermatitis (Eczema) Treatment Production Market Share & Forecast by Region, 2020-2031
Figure 15. Atopic Dermatitis (Eczema) Treatment Industry Chain
Figure 16. Atopic Dermatitis (Eczema) Treatment Procurement Model
Figure 17. Atopic Dermatitis (Eczema) Treatment Sales Model
Figure 18. Atopic Dermatitis (Eczema) Treatment Sales Channels, Direct Sales, and Distribution
Figure 19. Topical
Figure 20. Oral
Figure 21. Injectable
Figure 22. by Type, Global Atopic Dermatitis (Eczema) Treatment Consumption Value, 2020-2031, US$ Million
Figure 23. by Type, Global Atopic Dermatitis (Eczema) Treatment Consumption Value Market Share, 2020-2031
Figure 24. by Type, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Figure 25. by Type, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2020-2031
Figure 26. by Type, Global Atopic Dermatitis (Eczema) Treatment Average Selling Price (ASP), 2020-2031, (US$/Unit)
Figure 27. Hospital Pharmacies
Figure 28. Retail Pharmacies
Figure 29. Online Pharmacies
Figure 30. by Application, Global Atopic Dermatitis (Eczema) Treatment Consumption Value, 2020-2031, US$ Million
Figure 31. by Application, Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share, 2020-2031
Figure 32. by Application, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Figure 33. by Application, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2020-2031
Figure 34. by Application, Global Atopic Dermatitis (Eczema) Treatment Price, 2020-2031, (US$/Unit)
Figure 35. By Region, Global Atopic Dermatitis (Eczema) Treatment Consumption Value Market Share, 2020-2031
Figure 36. By Region, Global Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2020-2031
Figure 37. North America Atopic Dermatitis (Eczema) Treatment Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 38. By Country, North America Atopic Dermatitis (Eczema) Treatment Consumption Value Market Share, 2024
Figure 39. Europe Atopic Dermatitis (Eczema) Treatment Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 40. By Country, Europe Atopic Dermatitis (Eczema) Treatment Consumption Value Market Share, 2024
Figure 41. Asia Pacific Atopic Dermatitis (Eczema) Treatment Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 42. By Country/Region, Asia Pacific Atopic Dermatitis (Eczema) Treatment Consumption Value Market Share, 2024
Figure 43. South America Atopic Dermatitis (Eczema) Treatment Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 44. By Country, South America Atopic Dermatitis (Eczema) Treatment Consumption Value Market Share, 2024
Figure 45. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 46. United States Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Figure 47. by Type, United States Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 48. by Application, United States Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 49. Europe Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Figure 50. by Type, Europe Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 51. by Application, Europe Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 52. China Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Figure 53. by Type, China Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 54. by Application, China Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 55. Japan Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Figure 56. by Type, Japan Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 57. by Application, Japan Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 58. South Korea Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Figure 59. by Type, South Korea Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 60. by Application, South Korea Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 61. Southeast Asia Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Figure 62. by Type, Southeast Asia Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 63. by Application, Southeast Asia Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 64. India Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Figure 65. by Type, India Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 66. by Application, India Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 67. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Quantity, 2020-2031, (K Units)
Figure 68. by Type, Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 69. by Application, Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Quantity Market Share, 2024 VS 2031
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up Approaches
Figure 73. Top-down Approaches
Research Methodology:
Atopic Dermatitis (Eczema) Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|